Naglreiter has recently received its ISO 13485:2016 Quality Management System Certification for the following scope:
Design, Development, Manufacture and Distribution of implantable and non-implantable cardiovascular devices.
The full Quality Management System audit was completed in May of this year and the certification was received and is effective as of July 5th 2018.
NAGLREITER® MDDO sponsors the 15th Annual SNIS Meeting in San Francisco California. July 23- 26, 2018
Naglreiter is a proud sponsor for this year’s Society of NeuroInterventional Surgery conference taking place in San Francisco California. There will be multiple sessions which span the full spectrum of neurointervention to a strong slate of abstracts that reflect the shared vision for research. We invite you to join us at the Exhibitor’s Hall at our booth #605. We look forward to seeing you there.
NAGLREITER® MDDO becomes a Gold Sponsor at the 18th Annual New York City Venture Summit. July 10th – 11th 2018.
Naglreiter was proud to be a sponsor at this year’s New York City Venture Summit, an exclusive investment conference uniting venture capital and innovation. More than 100 Venture Capitalists from leading VC funds speak each year at the annual New York Venture Summit. The Summit attracts senior level executives (CEOs, Presidents, VPs, COOs, CFOs, and Managing Partners) of venture capital firms, investment banks, early stage and emerging growth companies from a variety of industries including: Software, IT, Wireless, Internet, Clean-tech, Life Sciences, Biotech, Healthcare, Investment and venture capital.
2018 Summer Internship – May 30, 2018
Naglreiter has officially kicked off its 2018 Summer Internship Program. This year we have three students who have joined our team. We at Naglreiter know internships give students the opportunity to gain valuable applied experience and make connections in professional fields. As employers, it gives us the opportunity to cultivate talent. We are pleased to have them join our team.
May 8, 2018
NAMSA and Naglreiter partner to provide Innovative Development Solution to Global Medical Device Manufacturers.
NAMSA Start-Up Summit – April 25, 2018
Boston, MA: It is not uncommon for early-stage medical device companies, often with few resources, to find it challenging to stay abreast of the requirements needed for successful product development and market introduction. NAMSA, in partnership with Naglreiter, will provide a unique half-day event for young device firms to learn about: 1) “The Product Development Process;” and 2) “FDA Trends & Guidance for Industry.”
NAMSA’s Start-Up Summit – March 21, 2018
Are you an early stage medical device organization in the Twin Cities area? Join NAMSA for our complimentary Start-Up Summit! NAMSA, in partnership with Naglreiter, will provide a unique half-day event for young device firms to learn about the product development process and FDA trends and guidance. Our experienced teams will share best practices and real-world lessons learned to help guide you on your path to successful product development.
November 9, 2017
Not all medical device incubators are the same. Brett Naglreiter offers several questions that will help to ensure you are choosing the right firm to enable you and your product to succeed.
October 16, 2017
NAGLREITER® Medical Device Development Organization uses a novel approach to shorten the timeline between medical device concept and device submission.
August 30, 2017
NAGLREITER® MDDO client receives U.S. FDA 510(k) clearance for the Hourglass™ Peripheral Embolisation Plug.
August 21, 2017
Brett Naglreiter shares his perspective on why you might consider partnering with a Medical Device Development Organization versus managing device development on your own.
April 21, 2017
Brett Naglreiter shares his point of view on medtech startups with Medical Design & Outsourcing.